Theralase Technologies Valuation
| TLT Stock | CAD 0.28 0.01 3.70% |
Theralase Technologies seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Theralase Technologies from inspecting the company fundamentals such as Shares Owned By Insiders of 8.70 %, current valuation of 68.13 M, and Return On Equity of -2.39 as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Theralase Technologies' valuation include:
Price Book 31.8562 | Enterprise Value | Enterprise Value Ebitda (12.06) | Price Sales 74.0147 | Enterprise Value Revenue 69.0534 |
Overvalued
Today
Please note that Theralase Technologies' price fluctuation is out of control at this time. Calculation of the real value of Theralase Technologies is based on 3 months time horizon. Increasing Theralase Technologies' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Theralase stock is determined by what a typical buyer is willing to pay for full or partial control of Theralase Technologies. Since Theralase Technologies is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Theralase Stock. However, Theralase Technologies' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.28 | Real 0.23 | Hype 0.28 | Naive 0.29 |
The intrinsic value of Theralase Technologies' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Theralase Technologies' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Theralase Technologies helps investors to forecast how Theralase stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Theralase Technologies more accurately as focusing exclusively on Theralase Technologies' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Theralase Technologies' intrinsic value based on its ongoing forecasts of Theralase Technologies' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Theralase Technologies' closest peers.
Theralase Technologies Cash |
|
Theralase Valuation Trend
Analysing the historical paterns of Theralase Technologies' enterprise value and its market capitalization is a good way to estimate and gauge the value of Theralase Technologies over time and is usually enough for investors to make rational market timing decisions.
Theralase Technologies Total Value Analysis
Theralase Technologies is at this time estimated to have takeover price of 68.13 M with market capitalization of 66.3 M, debt of 386.88 K, and cash on hands of 1.67 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Theralase Technologies fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
68.13 M | 66.3 M | 386.88 K | 1.67 M |
Theralase Technologies Investor Information
The company recorded a loss per share of 0.02. Theralase Technologies last dividend was issued on the February 1, 2011. Based on the key indicators related to Theralase Technologies' liquidity, profitability, solvency, and operating efficiency, Theralase Technologies is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Theralase Technologies Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Theralase Technologies has an asset utilization ratio of 32.66 percent. This indicates that the Company is making C$0.33 for each dollar of assets. An increasing asset utilization means that Theralase Technologies is more efficient with each dollar of assets it utilizes for everyday operations.Theralase Technologies Ownership Allocation
Theralase Technologies shows a total of 245.54 Million outstanding shares. Theralase Technologies has 8.7 % of its outstanding shares held by insiders and 0.0 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Theralase Technologies Profitability Analysis
The company reported the revenue of 1.07 M. Net Loss for the year was (4.57 M) with profit before overhead, payroll, taxes, and interest of 628.17 K.About Theralase Technologies Valuation
Our relative valuation model uses a comparative analysis of Theralase Technologies. We calculate exposure to Theralase Technologies's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Theralase Technologies's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 274.6 K | 260.9 K | |
| Pretax Profit Margin | (4.91) | (4.67) | |
| Operating Profit Margin | (4.94) | (4.69) | |
| Net Loss | (4.91) | (5.16) | |
| Gross Profit Margin | 0.60 | 0.65 |
Additional Tools for Theralase Stock Analysis
When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.